Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
A multicenter, registry-based, randomized clinical trial of added high-flow oxygen therapy during nighttime compared with usual care (low-flow oxygen therapy) alone in patients on long-term oxygen therapy due to COPD or interstitial lung disease (ILD). Primary composite outcome is time to all-cause hospitalization or death up to one year. The trial is conducted in collaboration with ResMed.
Coordinating Investigator: Magnus Ekström, Region Skåne.
ClinicalTrials.gov, ID: NCT06247397
